Rank | Gene Set | Z-score |
---|---|---|
1 | ribosomal small subunit assembly (GO:0000028) | 8.55947288 |
2 | * viral transcription (GO:0019083) | 8.36076814 |
3 | * translational termination (GO:0006415) | 8.01000598 |
4 | ribosomal small subunit biogenesis (GO:0042274) | 7.50591567 |
5 | * translational elongation (GO:0006414) | 6.92494374 |
6 | * SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.82878889 |
7 | * cotranslational protein targeting to membrane (GO:0006613) | 6.69913321 |
8 | * protein targeting to ER (GO:0045047) | 6.68548080 |
9 | maturation of SSU-rRNA (GO:0030490) | 6.39168860 |
10 | * establishment of protein localization to endoplasmic reticulum (GO:0072599) | 6.37998995 |
11 | * nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 6.31538182 |
12 | * protein localization to endoplasmic reticulum (GO:0070972) | 6.25376635 |
13 | * viral life cycle (GO:0019058) | 6.24635065 |
14 | * cellular protein complex disassembly (GO:0043624) | 6.17451568 |
15 | * translational initiation (GO:0006413) | 5.97496077 |
16 | * protein complex disassembly (GO:0043241) | 5.47807141 |
17 | ribosomal large subunit biogenesis (GO:0042273) | 5.35269958 |
18 | * macromolecular complex disassembly (GO:0032984) | 5.09742452 |
19 | * nuclear-transcribed mRNA catabolic process (GO:0000956) | 4.61465896 |
20 | * protein targeting to membrane (GO:0006612) | 4.42542389 |
21 | * mRNA catabolic process (GO:0006402) | 4.38621480 |
22 | * translation (GO:0006412) | 4.27542299 |
23 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.26461027 |
24 | formation of translation preinitiation complex (GO:0001731) | 4.15400661 |
25 | * RNA catabolic process (GO:0006401) | 4.12136279 |
26 | DNA deamination (GO:0045006) | 3.90748088 |
27 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.81243100 |
28 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.67542130 |
29 | DNA strand elongation (GO:0022616) | 3.63389207 |
30 | DNA unwinding involved in DNA replication (GO:0006268) | 3.54039555 |
31 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.52497077 |
32 | rRNA processing (GO:0006364) | 3.47163487 |
33 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.39837048 |
34 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.39837048 |
35 | modulation by symbiont of host immune response (GO:0052553) | 3.39837048 |
36 | positive regulation by symbiont of host defense response (GO:0052509) | 3.39837048 |
37 | modulation by symbiont of host defense response (GO:0052031) | 3.39837048 |
38 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.39837048 |
39 | rRNA metabolic process (GO:0016072) | 3.33688129 |
40 | telomere maintenance via recombination (GO:0000722) | 3.19782318 |
41 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.14777410 |
42 | cellular component biogenesis (GO:0044085) | 3.14251017 |
43 | NIK/NF-kappaB signaling (GO:0038061) | 3.12797056 |
44 | DNA replication initiation (GO:0006270) | 3.10803178 |
45 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.04508464 |
46 | negative regulation of cell killing (GO:0031342) | 3.04508464 |
47 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.02804651 |
48 | mitotic recombination (GO:0006312) | 2.96059188 |
49 | * establishment of protein localization to membrane (GO:0090150) | 2.95480058 |
50 | negative regulation of RNA splicing (GO:0033119) | 2.95263982 |
51 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.95190034 |
52 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.95190034 |
53 | modulation by virus of host process (GO:0019054) | 2.93654419 |
54 | establishment of integrated proviral latency (GO:0075713) | 2.92456879 |
55 | ncRNA 3-end processing (GO:0043628) | 2.89612509 |
56 | positive thymic T cell selection (GO:0045059) | 2.87919847 |
57 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.83860387 |
58 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.83546989 |
59 | telomere maintenance via telomere lengthening (GO:0010833) | 2.82236284 |
60 | modulation by symbiont of host cellular process (GO:0044068) | 2.82230383 |
61 | response to peptidoglycan (GO:0032494) | 2.81947915 |
62 | thymic T cell selection (GO:0045061) | 2.78876329 |
63 | myeloid cell homeostasis (GO:0002262) | 2.78749436 |
64 | activation of MAPKKK activity (GO:0000185) | 2.73186669 |
65 | * establishment of protein localization to organelle (GO:0072594) | 2.70945200 |
66 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.70219741 |
67 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.70052370 |
68 | spliceosomal snRNP assembly (GO:0000387) | 2.69212243 |
69 | * protein targeting (GO:0006605) | 2.68839589 |
70 | ribosome biogenesis (GO:0042254) | 2.65248928 |
71 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.64885456 |
72 | pinocytosis (GO:0006907) | 2.64124296 |
73 | * protein localization to membrane (GO:0072657) | 2.63003694 |
74 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.62656221 |
75 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.60379553 |
76 | nucleobase biosynthetic process (GO:0046112) | 2.60276486 |
77 | detection of bacterium (GO:0016045) | 2.58845896 |
78 | apoptotic process involved in morphogenesis (GO:0060561) | 2.58250050 |
79 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.57869850 |
80 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.57675998 |
81 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.56100091 |
82 | pseudouridine synthesis (GO:0001522) | 2.55801502 |
83 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.55499588 |
84 | response to muramyl dipeptide (GO:0032495) | 2.54736133 |
85 | positive regulation of T cell apoptotic process (GO:0070234) | 2.54477826 |
86 | negative regulation of ligase activity (GO:0051352) | 2.54000093 |
87 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.54000093 |
88 | cellular response to virus (GO:0098586) | 2.53672809 |
89 | immunoglobulin mediated immune response (GO:0016064) | 2.53086232 |
90 | leukocyte aggregation (GO:0070486) | 2.53025155 |
91 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.52077276 |
92 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.51596372 |
93 | spliceosomal complex assembly (GO:0000245) | 2.50088436 |
94 | regulation of protein heterodimerization activity (GO:0043497) | 2.49153307 |
95 | protein localization to kinetochore (GO:0034501) | 2.48391501 |
96 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.48314687 |
97 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.48314687 |
98 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.47974283 |
99 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.47864543 |
100 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.47358233 |
101 | detection of other organism (GO:0098543) | 2.46815574 |
102 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.46804243 |
103 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.45967691 |
104 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.45888962 |
105 | termination of RNA polymerase III transcription (GO:0006386) | 2.45888962 |
106 | IMP biosynthetic process (GO:0006188) | 2.45113029 |
107 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.45108863 |
108 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.45108863 |
109 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.45108863 |
110 | mRNA splicing, via spliceosome (GO:0000398) | 2.44433508 |
111 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.44433508 |
112 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.44341543 |
113 | pentose-phosphate shunt (GO:0006098) | 2.44134358 |
114 | ncRNA processing (GO:0034470) | 2.43973896 |
115 | RNA splicing, via transesterification reactions (GO:0000375) | 2.43810636 |
116 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.43117638 |
117 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.42706206 |
118 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.42706206 |
119 | proteasome assembly (GO:0043248) | 2.41653611 |
120 | CENP-A containing nucleosome assembly (GO:0034080) | 2.41301307 |
121 | establishment of viral latency (GO:0019043) | 2.41017894 |
122 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.40611532 |
123 | * gene expression (GO:0010467) | 2.40305373 |
124 | regulation of gamma-delta T cell activation (GO:0046643) | 2.39974350 |
125 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.39645331 |
126 | mannose metabolic process (GO:0006013) | 2.38848161 |
127 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.38556298 |
128 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.37815933 |
129 | pentose metabolic process (GO:0019321) | 2.36774075 |
130 | termination of RNA polymerase II transcription (GO:0006369) | 2.35830969 |
131 | negative regulation of interleukin-12 production (GO:0032695) | 2.35647472 |
132 | respiratory burst (GO:0045730) | 2.35507537 |
133 | lymphocyte apoptotic process (GO:0070227) | 2.35460310 |
134 | positive regulation of B cell differentiation (GO:0045579) | 2.34912579 |
135 | DNA replication checkpoint (GO:0000076) | 2.34148536 |
136 | chromatin remodeling at centromere (GO:0031055) | 2.34119007 |
137 | viral protein processing (GO:0019082) | 2.34016564 |
138 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.33395224 |
139 | viral mRNA export from host cell nucleus (GO:0046784) | 2.33043906 |
140 | T cell apoptotic process (GO:0070231) | 2.32995308 |
141 | heterochromatin organization (GO:0070828) | 2.32754244 |
142 | histone mRNA metabolic process (GO:0008334) | 2.31627231 |
143 | T cell selection (GO:0045058) | 2.29810337 |
144 | leukocyte apoptotic process (GO:0071887) | 2.29332975 |
145 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.29162026 |
146 | B cell receptor signaling pathway (GO:0050853) | 2.28816994 |
147 | ribonucleoprotein complex assembly (GO:0022618) | 2.28693516 |
148 | ribosome assembly (GO:0042255) | 2.28331723 |
149 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.28268652 |
150 | DNA replication-independent nucleosome organization (GO:0034724) | 2.28268652 |
151 | IMP metabolic process (GO:0046040) | 2.27130814 |
152 | * cellular component disassembly (GO:0022411) | 2.26975406 |
153 | negative thymic T cell selection (GO:0045060) | 2.26724232 |
154 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.26076458 |
155 | negative regulation of innate immune response (GO:0045824) | 2.25949986 |
156 | GDP-mannose metabolic process (GO:0019673) | 2.25273171 |
157 | myeloid dendritic cell differentiation (GO:0043011) | 2.24169060 |
158 | T cell migration (GO:0072678) | 2.22838521 |
159 | regulation of superoxide anion generation (GO:0032928) | 2.21167462 |
160 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.20524262 |
161 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.18679783 |
162 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.18475920 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.29540235 |
2 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.11051662 |
3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.86223157 |
4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.68433520 |
5 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.97900511 |
6 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.89429205 |
7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.86486438 |
8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.77194677 |
9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.66328080 |
10 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.66122774 |
11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.60157351 |
12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.52024057 |
13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.51805511 |
14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.50106799 |
15 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.48736506 |
16 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.46340214 |
17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.40479060 |
18 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.39830787 |
19 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.35740488 |
20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.33920253 |
21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.33645345 |
22 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.20888243 |
23 | MYC_22102868_ChIP-Seq_BL_Human | 2.20625967 |
24 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.20612529 |
25 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17204932 |
26 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.14861050 |
27 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.02252693 |
28 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.01327797 |
29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.99427889 |
30 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.95802325 |
31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.94863918 |
32 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.91065494 |
33 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.86627005 |
34 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.86443476 |
35 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.82172967 |
36 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78846347 |
37 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.77375967 |
38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.76489730 |
39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.75540977 |
40 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.75506102 |
41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.75349358 |
42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.74726153 |
43 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.73720596 |
44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.68626033 |
45 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.68169017 |
46 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.65903408 |
47 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.63400355 |
48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.60555540 |
49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.59413173 |
50 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.58841723 |
51 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.58680300 |
52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.58497702 |
53 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.58425369 |
54 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.54660942 |
55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54541514 |
56 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.53593321 |
57 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.52792685 |
58 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.52527318 |
59 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.50060536 |
60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46196953 |
61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44494050 |
62 | P68_20966046_ChIP-Seq_HELA_Human | 1.44349505 |
63 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.42969809 |
64 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.42945314 |
65 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.42839388 |
66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.41783663 |
67 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.40186863 |
68 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.39821838 |
69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38499540 |
70 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.37581752 |
71 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37159723 |
72 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.36169797 |
73 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35412417 |
74 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.31849888 |
75 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.30166314 |
76 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29803807 |
77 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.29458108 |
78 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.29355462 |
79 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29192066 |
80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28990671 |
81 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28849815 |
82 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.28023598 |
83 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27622113 |
84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27155757 |
85 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.27045104 |
86 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.26849426 |
87 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.26086358 |
88 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.23824640 |
89 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.22262185 |
90 | * MAF_26560356_Chip-Seq_TH1_Human | 1.22059723 |
91 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.21594776 |
92 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.20860689 |
93 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.20458774 |
94 | MYB_26560356_Chip-Seq_TH2_Human | 1.18340980 |
95 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.18293966 |
96 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17128812 |
97 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.16651876 |
98 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16650731 |
99 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16139896 |
100 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.15788929 |
101 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.15399540 |
102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14036996 |
103 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.12895501 |
104 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.12537092 |
105 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11938176 |
106 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.11369465 |
107 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.10287630 |
108 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.10272093 |
109 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.09441876 |
110 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09069054 |
111 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.08854679 |
112 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.08517103 |
113 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.08218477 |
114 | MAF_26560356_Chip-Seq_TH2_Human | 1.07818849 |
115 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07156459 |
116 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06648372 |
117 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06350074 |
118 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05990691 |
119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.05285369 |
120 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05114873 |
121 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04531708 |
122 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03706545 |
123 | MYB_26560356_Chip-Seq_TH1_Human | 1.03399492 |
124 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.03268778 |
125 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.02655836 |
126 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.02427507 |
127 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01540841 |
128 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.01010024 |
129 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00647371 |
130 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.98860018 |
131 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.98475049 |
132 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97576569 |
133 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.96843806 |
134 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96392664 |
135 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.95911349 |
136 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.94900504 |
137 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.94724630 |
138 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.93501158 |
139 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.92202878 |
140 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.91306813 |
141 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90521182 |
142 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.89069556 |
143 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88743940 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 3.68855409 |
2 | MP0002396_abnormal_hematopoietic_system | 3.06793318 |
3 | MP0009379_abnormal_foot_pigmentation | 2.96922871 |
4 | MP0004957_abnormal_blastocyst_morpholog | 2.94407167 |
5 | MP0010094_abnormal_chromosome_stability | 2.71454075 |
6 | MP0003077_abnormal_cell_cycle | 2.67886267 |
7 | MP0001835_abnormal_antigen_presentation | 2.57522106 |
8 | MP0003763_abnormal_thymus_physiology | 2.51133474 |
9 | MP0003111_abnormal_nucleus_morphology | 2.44230228 |
10 | MP0008057_abnormal_DNA_replication | 2.32895217 |
11 | MP0000685_abnormal_immune_system | 2.30611138 |
12 | MP0003705_abnormal_hypodermis_morpholog | 2.29125049 |
13 | MP0009333_abnormal_splenocyte_physiolog | 2.25937075 |
14 | MP0005058_abnormal_lysosome_morphology | 2.25375657 |
15 | MP0000490_abnormal_crypts_of | 2.14004053 |
16 | MP0005451_abnormal_body_composition | 2.11665961 |
17 | MP0004808_abnormal_hematopoietic_stem | 2.04790138 |
18 | MP0008007_abnormal_cellular_replicative | 2.02246231 |
19 | MP0001800_abnormal_humoral_immune | 2.02018980 |
20 | MP0002398_abnormal_bone_marrow | 2.00327483 |
21 | MP0005671_abnormal_response_to | 1.96078302 |
22 | MP0008058_abnormal_DNA_repair | 1.91595254 |
23 | MP0009785_altered_susceptibility_to | 1.86928693 |
24 | MP0004185_abnormal_adipocyte_glucose | 1.83595127 |
25 | MP0002452_abnormal_antigen_presenting | 1.79149247 |
26 | MP0002420_abnormal_adaptive_immunity | 1.78445738 |
27 | MP0001819_abnormal_immune_cell | 1.75700930 |
28 | MP0002722_abnormal_immune_system | 1.74357545 |
29 | MP0000689_abnormal_spleen_morphology | 1.68982248 |
30 | MP0002723_abnormal_immune_serum | 1.67535685 |
31 | MP0010352_gastrointestinal_tract_polyps | 1.67273136 |
32 | MP0005397_hematopoietic_system_phenotyp | 1.67185239 |
33 | MP0001545_abnormal_hematopoietic_system | 1.67185239 |
34 | MP0005025_abnormal_response_to | 1.67059664 |
35 | MP0005000_abnormal_immune_tolerance | 1.66471536 |
36 | MP0000716_abnormal_immune_system | 1.65767033 |
37 | MP0000703_abnormal_thymus_morphology | 1.64816361 |
38 | MP0002166_altered_tumor_susceptibility | 1.63287428 |
39 | MP0005174_abnormal_tail_pigmentation | 1.59536893 |
40 | MP0009840_abnormal_foam_cell | 1.59472787 |
41 | MP0002429_abnormal_blood_cell | 1.59229753 |
42 | MP0000465_gastrointestinal_hemorrhage | 1.57986899 |
43 | MP0002148_abnormal_hypersensitivity_rea | 1.57012162 |
44 | MP0008932_abnormal_embryonic_tissue | 1.56174276 |
45 | MP0008260_abnormal_autophagy | 1.55830434 |
46 | MP0001790_abnormal_immune_system | 1.55076982 |
47 | MP0005387_immune_system_phenotype | 1.55076982 |
48 | MP0006054_spinal_hemorrhage | 1.54757544 |
49 | MP0002405_respiratory_system_inflammati | 1.52432640 |
50 | MP0003436_decreased_susceptibility_to | 1.51161042 |
51 | MP0010155_abnormal_intestine_physiology | 1.48381813 |
52 | MP0000350_abnormal_cell_proliferation | 1.44459966 |
53 | MP0001853_heart_inflammation | 1.43986504 |
54 | MP0002019_abnormal_tumor_incidence | 1.42052684 |
55 | MP0001873_stomach_inflammation | 1.41391923 |
56 | MP0002796_impaired_skin_barrier | 1.40556464 |
57 | MP0003866_abnormal_defecation | 1.35438608 |
58 | MP0005075_abnormal_melanosome_morpholog | 1.34452598 |
59 | MP0002132_abnormal_respiratory_system | 1.33952955 |
60 | MP0001730_embryonic_growth_arrest | 1.33438870 |
61 | MP0002006_tumorigenesis | 1.33227916 |
62 | MP0003786_premature_aging | 1.32488986 |
63 | MP0009278_abnormal_bone_marrow | 1.31915416 |
64 | MP0004858_abnormal_nervous_system | 1.27679347 |
65 | MP0000678_abnormal_parathyroid_gland | 1.26268287 |
66 | MP0003453_abnormal_keratinocyte_physiol | 1.24631265 |
67 | MP0001849_ear_inflammation | 1.22416001 |
68 | MP0005464_abnormal_platelet_physiology | 1.21641364 |
69 | MP0000313_abnormal_cell_death | 1.20854441 |
70 | MP0000858_altered_metastatic_potential | 1.20228548 |
71 | MP0002163_abnormal_gland_morphology | 1.19408170 |
72 | MP0002095_abnormal_skin_pigmentation | 1.18307900 |
73 | MP0005076_abnormal_cell_differentiation | 1.18296091 |
74 | MP0003567_abnormal_fetal_cardiomyocyte | 1.16760317 |
75 | MP0003191_abnormal_cellular_cholesterol | 1.15941199 |
76 | MP0002419_abnormal_innate_immunity | 1.14431996 |
77 | MP0006082_CNS_inflammation | 1.10587862 |
78 | MP0002998_abnormal_bone_remodeling | 1.04503901 |
79 | MP0003806_abnormal_nucleotide_metabolis | 1.04441978 |
80 | MP0005666_abnormal_adipose_tissue | 1.00743230 |
81 | MP0001845_abnormal_inflammatory_respons | 0.99099218 |
82 | MP0004947_skin_inflammation | 0.97979637 |
83 | MP0002080_prenatal_lethality | 0.97343377 |
84 | MP0003724_increased_susceptibility_to | 0.96448649 |
85 | MP0004510_myositis | 0.93423904 |
86 | MP0001697_abnormal_embryo_size | 0.92475103 |
87 | MP0002877_abnormal_melanocyte_morpholog | 0.92374002 |
88 | MP0010307_abnormal_tumor_latency | 0.92317251 |
89 | MP0002254_reproductive_system_inflammat | 0.91598902 |
90 | MP0002938_white_spotting | 0.90730196 |
91 | MP0000477_abnormal_intestine_morphology | 0.86978194 |
92 | MP0000750_abnormal_muscle_regeneration | 0.86687037 |
93 | MP0003315_abnormal_perineum_morphology | 0.85473090 |
94 | MP0003186_abnormal_redox_activity | 0.85336545 |
95 | MP0004381_abnormal_hair_follicle | 0.83695113 |
96 | MP0005023_abnormal_wound_healing | 0.83459993 |
97 | MP0002933_joint_inflammation | 0.82786593 |
98 | MP0000343_altered_response_to | 0.81832734 |
99 | MP0009053_abnormal_anal_canal | 0.81220402 |
100 | MP0001672_abnormal_embryogenesis/_devel | 0.80198314 |
101 | MP0005380_embryogenesis_phenotype | 0.80198314 |
102 | MP0005501_abnormal_skin_physiology | 0.80135549 |
103 | MP0001348_abnormal_lacrimal_gland | 0.76145445 |
104 | MP0003123_paternal_imprinting | 0.75786353 |
105 | MP0005390_skeleton_phenotype | 0.75732107 |
106 | MP0003984_embryonic_growth_retardation | 0.75416908 |
107 | MP0005310_abnormal_salivary_gland | 0.75054477 |
108 | MP0005381_digestive/alimentary_phenotyp | 0.74920059 |
109 | MP0002088_abnormal_embryonic_growth/wei | 0.74107272 |
110 | MP0003448_altered_tumor_morphology | 0.74090535 |
111 | MP0002085_abnormal_embryonic_tissue | 0.74049666 |
112 | MP0002086_abnormal_extraembryonic_tissu | 0.73979066 |
113 | MP0002138_abnormal_hepatobiliary_system | 0.73665676 |
114 | MP0003172_abnormal_lysosome_physiology | 0.72417855 |
115 | MP0001727_abnormal_embryo_implantation | 0.71025528 |
116 | MP0004197_abnormal_fetal_growth/weight/ | 0.68967917 |
117 | MP0001216_abnormal_epidermal_layer | 0.67979667 |
118 | MP0004264_abnormal_extraembryonic_tissu | 0.66730880 |
119 | MP0001293_anophthalmia | 0.66090439 |
120 | MP0009764_decreased_sensitivity_to | 0.64125281 |
121 | MP0002084_abnormal_developmental_patter | 0.63903424 |
122 | MP0002089_abnormal_postnatal_growth/wei | 0.63177018 |
123 | MP0009931_abnormal_skin_appearance | 0.62823709 |
124 | MP0010030_abnormal_orbit_morphology | 0.60474726 |
125 | MP0003300_gastrointestinal_ulcer | 0.58761928 |
126 | MP0008469_abnormal_protein_level | 0.58086981 |
127 | MP0000358_abnormal_cell_content/ | 0.57942621 |
128 | MP0000372_irregular_coat_pigmentation | 0.56844732 |
129 | MP0001533_abnormal_skeleton_physiology | 0.55396954 |
130 | MP0003566_abnormal_cell_adhesion | 0.54961027 |
131 | MP0003303_peritoneal_inflammation | 0.54656002 |
132 | MP0001663_abnormal_digestive_system | 0.54444679 |
133 | MP0002277_abnormal_respiratory_mucosa | 0.54376888 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 7.77774385 |
2 | Abnormal number of erythroid precursors (HP:0012131) | 7.01908743 |
3 | Reticulocytopenia (HP:0001896) | 6.93104436 |
4 | Macrocytic anemia (HP:0001972) | 4.98606013 |
5 | Pallor (HP:0000980) | 4.81764485 |
6 | Thrombocytosis (HP:0001894) | 4.21575933 |
7 | IgM deficiency (HP:0002850) | 3.55742475 |
8 | Aplastic anemia (HP:0001915) | 3.48949423 |
9 | Colon cancer (HP:0003003) | 3.25420122 |
10 | Gastrointestinal stroma tumor (HP:0100723) | 3.10051004 |
11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.09847247 |
12 | Abnormality of macrophages (HP:0004311) | 3.05275852 |
13 | Chronic otitis media (HP:0000389) | 3.02064911 |
14 | Mediastinal lymphadenopathy (HP:0100721) | 2.98571668 |
15 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.97496346 |
16 | 11 pairs of ribs (HP:0000878) | 2.96734217 |
17 | Increased IgE level (HP:0003212) | 2.88246529 |
18 | Colitis (HP:0002583) | 2.80012013 |
19 | Recurrent bronchitis (HP:0002837) | 2.74257651 |
20 | Hypertensive crisis (HP:0100735) | 2.61353164 |
21 | Petechiae (HP:0000967) | 2.58570009 |
22 | Hyperacusis (HP:0010780) | 2.54036940 |
23 | Oral leukoplakia (HP:0002745) | 2.51350113 |
24 | Multiple enchondromatosis (HP:0005701) | 2.48360239 |
25 | Panhypogammaglobulinemia (HP:0003139) | 2.47247837 |
26 | Recurrent viral infections (HP:0004429) | 2.45608895 |
27 | Absent thumb (HP:0009777) | 2.45563659 |
28 | Progressive muscle weakness (HP:0003323) | 2.44130087 |
29 | Abnormality of T cells (HP:0002843) | 2.41744589 |
30 | Deep palmar crease (HP:0006191) | 2.41320468 |
31 | Polygenic inheritance (HP:0010982) | 2.39350662 |
32 | Selective tooth agenesis (HP:0001592) | 2.35694279 |
33 | Abnormality of T cell physiology (HP:0011840) | 2.33930804 |
34 | Birth length less than 3rd percentile (HP:0003561) | 2.31585496 |
35 | Lymphoma (HP:0002665) | 2.30867399 |
36 | Trismus (HP:0000211) | 2.30659642 |
37 | Abnormality of reticulocytes (HP:0004312) | 2.28886078 |
38 | Thoracic kyphosis (HP:0002942) | 2.25459461 |
39 | Cellulitis (HP:0100658) | 2.23937901 |
40 | Asplenia (HP:0001746) | 2.23681876 |
41 | Achilles tendon contracture (HP:0001771) | 2.23075589 |
42 | T lymphocytopenia (HP:0005403) | 2.23031475 |
43 | Myositis (HP:0100614) | 2.22614905 |
44 | Recurrent abscess formation (HP:0002722) | 2.22046996 |
45 | Poikiloderma (HP:0001029) | 2.21622908 |
46 | Myelodysplasia (HP:0002863) | 2.20014603 |
47 | Increased cerebral lipofuscin (HP:0011813) | 2.19540361 |
48 | Emphysema (HP:0002097) | 2.17323203 |
49 | B lymphocytopenia (HP:0010976) | 2.16112195 |
50 | Abnormality of B cell number (HP:0010975) | 2.16112195 |
51 | Agammaglobulinemia (HP:0004432) | 2.15966750 |
52 | Depressed nasal ridge (HP:0000457) | 2.15721734 |
53 | Recurrent skin infections (HP:0001581) | 2.15668862 |
54 | Urticaria (HP:0001025) | 2.15071181 |
55 | Abnormality of T cell number (HP:0011839) | 2.13711904 |
56 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.13493447 |
57 | Basal cell carcinoma (HP:0002671) | 2.12733729 |
58 | Ragged-red muscle fibers (HP:0003200) | 2.12374608 |
59 | Vertebral compression fractures (HP:0002953) | 2.10421663 |
60 | IgG deficiency (HP:0004315) | 2.09725655 |
61 | Abnormality of the thoracic spine (HP:0100711) | 2.09160316 |
62 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.08413054 |
63 | Microretrognathia (HP:0000308) | 2.07632328 |
64 | Long palpebral fissure (HP:0000637) | 2.07631325 |
65 | Stenosis of the external auditory canal (HP:0000402) | 2.05675758 |
66 | Vasculitis (HP:0002633) | 2.05597986 |
67 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.04901526 |
68 | Recurrent cutaneous fungal infections (HP:0011370) | 2.04901526 |
69 | Lymphopenia (HP:0001888) | 2.03530035 |
70 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.02739964 |
71 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.01248681 |
72 | Recurrent fungal infections (HP:0002841) | 2.01242146 |
73 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.00842974 |
74 | Rough bone trabeculation (HP:0100670) | 2.00809179 |
75 | Pustule (HP:0200039) | 2.00202702 |
76 | Broad distal phalanx of finger (HP:0009836) | 1.99422843 |
77 | Increased IgM level (HP:0003496) | 1.98222927 |
78 | Meningitis (HP:0001287) | 1.96390711 |
79 | Abnormal hemoglobin (HP:0011902) | 1.95537840 |
80 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.94194765 |
81 | Partial duplication of thumb phalanx (HP:0009944) | 1.94087182 |
82 | Carpal bone hypoplasia (HP:0001498) | 1.93870598 |
83 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.93845386 |
84 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.93845386 |
85 | Amaurosis fugax (HP:0100576) | 1.93652067 |
86 | Exertional dyspnea (HP:0002875) | 1.93087240 |
87 | Migraine (HP:0002076) | 1.93044663 |
88 | Glossoptosis (HP:0000162) | 1.92740779 |
89 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.92047198 |
90 | Granulocytopenia (HP:0001913) | 1.90233680 |
91 | Prolonged bleeding time (HP:0003010) | 1.87021631 |
92 | Congenital, generalized hypertrichosis (HP:0004540) | 1.86902758 |
93 | Encephalitis (HP:0002383) | 1.84988682 |
94 | Gastrointestinal inflammation (HP:0004386) | 1.84877893 |
95 | Recurrent bacterial skin infections (HP:0005406) | 1.84614983 |
96 | Thick lower lip vermilion (HP:0000179) | 1.84179985 |
97 | Increased serum ferritin (HP:0003281) | 1.83716948 |
98 | Abnormal number of incisors (HP:0011064) | 1.83343260 |
99 | Abnormality of the Achilles tendon (HP:0005109) | 1.83175199 |
100 | Seborrheic dermatitis (HP:0001051) | 1.81634012 |
101 | Microvesicular hepatic steatosis (HP:0001414) | 1.81515012 |
102 | Increased muscle lipid content (HP:0009058) | 1.81439593 |
103 | Breast hypoplasia (HP:0003187) | 1.79974622 |
104 | Nasal polyposis (HP:0100582) | 1.79870334 |
105 | Pancytopenia (HP:0001876) | 1.78599578 |
106 | Premature graying of hair (HP:0002216) | 1.78493000 |
107 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.78245021 |
108 | Severe combined immunodeficiency (HP:0004430) | 1.77608165 |
109 | Patellar aplasia (HP:0006443) | 1.76967905 |
110 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.76807354 |
111 | Cellular immunodeficiency (HP:0005374) | 1.76469560 |
112 | Cleft eyelid (HP:0000625) | 1.76332457 |
113 | Viral hepatitis (HP:0006562) | 1.76203292 |
114 | Combined immunodeficiency (HP:0005387) | 1.76109632 |
115 | Type I transferrin isoform profile (HP:0003642) | 1.75970551 |
116 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.75614099 |
117 | Hypergammaglobulinemia (HP:0010702) | 1.75555651 |
118 | Progressive external ophthalmoplegia (HP:0000590) | 1.75532681 |
119 | Hypoplasia of the radius (HP:0002984) | 1.75345049 |
120 | Neoplasm of the pancreas (HP:0002894) | 1.75204251 |
121 | Thin bony cortex (HP:0002753) | 1.74893407 |
122 | Verrucae (HP:0200043) | 1.74743064 |
123 | Papilloma (HP:0012740) | 1.74743064 |
124 | Partial duplication of the phalanx of hand (HP:0009999) | 1.74478558 |
125 | Gingivitis (HP:0000230) | 1.74460944 |
126 | Inflammation of the large intestine (HP:0002037) | 1.74016589 |
127 | Degeneration of anterior horn cells (HP:0002398) | 1.73683615 |
128 | Abnormality of the anterior horn cell (HP:0006802) | 1.73683615 |
129 | Triphalangeal thumb (HP:0001199) | 1.71941488 |
130 | Increased hepatocellular lipid droplets (HP:0006565) | 1.71528523 |
131 | Muscle fiber atrophy (HP:0100295) | 1.71504224 |
132 | Disproportionate tall stature (HP:0001519) | 1.71114127 |
133 | Spinal cord lesions (HP:0100561) | 1.70987578 |
134 | Syringomyelia (HP:0003396) | 1.70987578 |
135 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.70842474 |
136 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.70842474 |
137 | Abnormality of glycolipid metabolism (HP:0010969) | 1.70842474 |
138 | Agnosia (HP:0010524) | 1.70568356 |
139 | Restrictive lung disease (HP:0002091) | 1.70516049 |
140 | Increased intramyocellular lipid droplets (HP:0012240) | 1.69819664 |
141 | Abnormality of the nasal mucosa (HP:0000433) | 1.69743199 |
142 | Orchitis (HP:0100796) | 1.68539630 |
143 | Bone marrow hypocellularity (HP:0005528) | 1.68387344 |
144 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.68287430 |
145 | Gastrointestinal infarctions (HP:0005244) | 1.68132068 |
146 | Acute lymphatic leukemia (HP:0006721) | 1.67642015 |
147 | Obstructive lung disease (HP:0006536) | 1.67434481 |
148 | Chronic obstructive pulmonary disease (HP:0006510) | 1.67434481 |
149 | Eczematoid dermatitis (HP:0000976) | 1.66284522 |
150 | Eosinophilia (HP:0001880) | 1.66189890 |
151 | Missing ribs (HP:0000921) | 1.65850141 |
152 | Recurrent lower respiratory tract infections (HP:0002783) | 1.65534230 |
153 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.64867938 |
154 | Skin ulcer (HP:0200042) | 1.64646222 |
155 | Abnormality of the preputium (HP:0100587) | 1.64642277 |
156 | Respiratory difficulties (HP:0002880) | 1.63846698 |
157 | Purpura (HP:0000979) | 1.62649766 |
158 | IgA deficiency (HP:0002720) | 1.61754677 |
159 | Squamous cell carcinoma (HP:0002860) | 1.61615233 |
160 | Hyperparathyroidism (HP:0000843) | 1.58987150 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NME2 | 4.34694407 |
2 | SMG1 | 3.87295619 |
3 | MAP4K1 | 3.25481690 |
4 | PRPF4B | 3.20378097 |
5 | EEF2K | 3.19536060 |
6 | BUB1 | 2.96330041 |
7 | WEE1 | 2.72825609 |
8 | RPS6KB2 | 2.43580318 |
9 | LRRK2 | 2.23087890 |
10 | TGFBR1 | 2.21234968 |
11 | VRK2 | 1.99797605 |
12 | PIM2 | 1.98493204 |
13 | STK16 | 1.97880083 |
14 | PASK | 1.88077024 |
15 | CDC7 | 1.82306718 |
16 | ICK | 1.75009687 |
17 | RIPK4 | 1.74387269 |
18 | ARAF | 1.73928197 |
19 | BTK | 1.69667166 |
20 | MAP3K10 | 1.68532765 |
21 | FLT3 | 1.67419307 |
22 | DYRK3 | 1.65995376 |
23 | VRK1 | 1.64270469 |
24 | MST4 | 1.61941290 |
25 | SIK1 | 1.61699711 |
26 | MAP3K13 | 1.60320221 |
27 | TESK2 | 1.59974424 |
28 | SRPK1 | 1.56623894 |
29 | EIF2AK1 | 1.56551183 |
30 | KIT | 1.55894341 |
31 | RPS6KA4 | 1.55510693 |
32 | NEK2 | 1.55392673 |
33 | STK10 | 1.53136255 |
34 | BLK | 1.49141200 |
35 | ZAP70 | 1.46816847 |
36 | TEC | 1.41587274 |
37 | TSSK6 | 1.39559625 |
38 | TAOK2 | 1.38791319 |
39 | TLK1 | 1.35560794 |
40 | MAP2K3 | 1.34025619 |
41 | ACVR1B | 1.31997023 |
42 | PKN2 | 1.30742821 |
43 | MKNK1 | 1.27433786 |
44 | BRAF | 1.25425614 |
45 | CSF1R | 1.24091696 |
46 | EIF2AK3 | 1.23400414 |
47 | CDK12 | 1.21046621 |
48 | PIM1 | 1.20554824 |
49 | TYK2 | 1.18737440 |
50 | MAP3K14 | 1.18600914 |
51 | KDR | 1.18361462 |
52 | CLK1 | 1.17401051 |
53 | JAK3 | 1.15518737 |
54 | CDK7 | 1.14983443 |
55 | MAPKAPK3 | 1.14557056 |
56 | GRK6 | 1.13230308 |
57 | AURKB | 1.13032568 |
58 | BRSK2 | 1.11105028 |
59 | TXK | 1.10630059 |
60 | IKBKB | 1.05733176 |
61 | FGFR4 | 1.05484366 |
62 | PAK4 | 1.04613339 |
63 | ILK | 1.03489413 |
64 | MAP3K8 | 1.01592357 |
65 | CSK | 0.99548746 |
66 | ATR | 0.98073014 |
67 | IRAK4 | 0.97050176 |
68 | TBK1 | 0.96715103 |
69 | SYK | 0.95693001 |
70 | CDK4 | 0.94935610 |
71 | STK4 | 0.93830635 |
72 | PTK6 | 0.87734749 |
73 | NLK | 0.86917124 |
74 | IRAK2 | 0.83286211 |
75 | DAPK3 | 0.82289949 |
76 | FES | 0.79754514 |
77 | ITK | 0.79422161 |
78 | PLK1 | 0.79291974 |
79 | MAP3K1 | 0.79261983 |
80 | LCK | 0.78753956 |
81 | RIPK1 | 0.76925225 |
82 | IKBKE | 0.75080555 |
83 | CDK19 | 0.74490466 |
84 | LYN | 0.71672049 |
85 | SCYL2 | 0.71280407 |
86 | RPS6KA5 | 0.70969168 |
87 | PDPK1 | 0.69843865 |
88 | HIPK2 | 0.69218427 |
89 | MAP3K11 | 0.65269281 |
90 | CDC42BPA | 0.64379488 |
91 | TYRO3 | 0.63037971 |
92 | TTK | 0.62488765 |
93 | CSNK2A2 | 0.61247862 |
94 | MARK2 | 0.60740701 |
95 | RPS6KA2 | 0.59635235 |
96 | TAOK1 | 0.59526751 |
97 | MAP2K2 | 0.59172705 |
98 | TAF1 | 0.58728591 |
99 | MAP3K3 | 0.57523781 |
100 | CDK8 | 0.56876405 |
101 | MAPK11 | 0.56617800 |
102 | MTOR | 0.55733081 |
103 | ABL2 | 0.54786559 |
104 | PLK4 | 0.53636787 |
105 | PRKD2 | 0.53300023 |
106 | AURKA | 0.52039567 |
107 | CHEK1 | 0.51613816 |
108 | MOS | 0.51399329 |
109 | PAK1 | 0.51212692 |
110 | CSNK2A1 | 0.50969033 |
111 | TESK1 | 0.50713531 |
112 | DYRK1B | 0.49949715 |
113 | KSR2 | 0.49762173 |
114 | EPHB2 | 0.49291863 |
115 | RPS6KA1 | 0.48926085 |
116 | TGFBR2 | 0.48447353 |
117 | RPS6KA6 | 0.47575406 |
118 | HCK | 0.47080379 |
119 | NME1 | 0.46343992 |
120 | TTN | 0.46198255 |
121 | MAPKAPK2 | 0.45674630 |
122 | TRIB3 | 0.44884190 |
123 | CDK6 | 0.43013092 |
124 | CHUK | 0.42257626 |
125 | RPS6KL1 | 0.41876531 |
126 | RPS6KC1 | 0.41876531 |
127 | PAK2 | 0.41069925 |
128 | MARK3 | 0.41044271 |
129 | SIK2 | 0.40993750 |
130 | MKNK2 | 0.40963783 |
131 | CDK9 | 0.40460604 |
132 | MATK | 0.40348265 |
133 | PDK1 | 0.39423727 |
134 | CAMKK1 | 0.38519996 |
135 | PRKD3 | 0.38443433 |
136 | CHEK2 | 0.38061162 |
137 | MAPKAPK5 | 0.37691680 |
138 | BMX | 0.37601083 |
139 | EPHA2 | 0.34970575 |
140 | IRAK3 | 0.33871943 |
141 | ERN1 | 0.33399390 |
142 | BRSK1 | 0.32968910 |
143 | CDK2 | 0.31629730 |
144 | MAP2K6 | 0.30691976 |
145 | TRPM7 | 0.30515216 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Ribosome_Homo sapiens_hsa03010 | 6.47128473 |
2 | DNA replication_Homo sapiens_hsa03030 | 3.97282442 |
3 | Mismatch repair_Homo sapiens_hsa03430 | 3.27433845 |
4 | Proteasome_Homo sapiens_hsa03050 | 3.06248913 |
5 | Spliceosome_Homo sapiens_hsa03040 | 2.92769876 |
6 | RNA polymerase_Homo sapiens_hsa03020 | 2.82965968 |
7 | Base excision repair_Homo sapiens_hsa03410 | 2.51148184 |
8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.32276241 |
9 | Homologous recombination_Homo sapiens_hsa03440 | 2.30717762 |
10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.27803846 |
11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.12997772 |
12 | RNA transport_Homo sapiens_hsa03013 | 2.05840790 |
13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.02656680 |
14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.77610424 |
15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.73609224 |
16 | Cell cycle_Homo sapiens_hsa04110 | 1.65348744 |
17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.53439822 |
18 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.52655455 |
19 | RNA degradation_Homo sapiens_hsa03018 | 1.42026755 |
20 | Protein export_Homo sapiens_hsa03060 | 1.41181642 |
21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38472637 |
22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.38366408 |
23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.35401235 |
24 | Bladder cancer_Homo sapiens_hsa05219 | 1.34915110 |
25 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.29108398 |
26 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.20587183 |
27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.20356832 |
28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.19790740 |
29 | Basal transcription factors_Homo sapiens_hsa03022 | 1.18980690 |
30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14054146 |
31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12376191 |
32 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.11607584 |
33 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.11221760 |
34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10133339 |
35 | Parkinsons disease_Homo sapiens_hsa05012 | 1.09779479 |
36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.07940312 |
37 | Measles_Homo sapiens_hsa05162 | 1.06440689 |
38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04631467 |
39 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03707977 |
40 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.00773464 |
41 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.98998167 |
42 | Galactose metabolism_Homo sapiens_hsa00052 | 0.98414042 |
43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96543337 |
44 | Purine metabolism_Homo sapiens_hsa00230 | 0.96260353 |
45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.93873460 |
46 | Leishmaniasis_Homo sapiens_hsa05140 | 0.93809909 |
47 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.90770773 |
48 | Legionellosis_Homo sapiens_hsa05134 | 0.90697828 |
49 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.87862173 |
50 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86741099 |
51 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.85085071 |
52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84863824 |
53 | Huntingtons disease_Homo sapiens_hsa05016 | 0.84350256 |
54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83772847 |
55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81115638 |
56 | Allograft rejection_Homo sapiens_hsa05330 | 0.79382736 |
57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.78049255 |
58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76673450 |
59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76317307 |
60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75874861 |
61 | Shigellosis_Homo sapiens_hsa05131 | 0.75850549 |
62 | Apoptosis_Homo sapiens_hsa04210 | 0.75512282 |
63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74752433 |
64 | Prion diseases_Homo sapiens_hsa05020 | 0.74289247 |
65 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.71623530 |
66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71006833 |
67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70105036 |
68 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67335128 |
69 | Endometrial cancer_Homo sapiens_hsa05213 | 0.66903290 |
70 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66726899 |
71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65483875 |
72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65090092 |
73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63904118 |
74 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63664570 |
75 | Asthma_Homo sapiens_hsa05310 | 0.63599630 |
76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63440966 |
77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.59813040 |
78 | Hepatitis B_Homo sapiens_hsa05161 | 0.59440830 |
79 | Lysosome_Homo sapiens_hsa04142 | 0.59253743 |
80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.57032369 |
81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55542944 |
82 | Influenza A_Homo sapiens_hsa05164 | 0.54987186 |
83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54810776 |
84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.54343445 |
85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.52552136 |
86 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52543736 |
87 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52514049 |
88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52473176 |
89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51653354 |
90 | Alzheimers disease_Homo sapiens_hsa05010 | 0.51380422 |
91 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.50957532 |
92 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.50333069 |
93 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.50122230 |
94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49889936 |
95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49790509 |
96 | Phagosome_Homo sapiens_hsa04145 | 0.49296938 |
97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48638059 |
98 | Pertussis_Homo sapiens_hsa05133 | 0.45220178 |
99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44988052 |
100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44826302 |
101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43789776 |
102 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.43539992 |
103 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42666502 |
104 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42341787 |
105 | Prostate cancer_Homo sapiens_hsa05215 | 0.41893232 |
106 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.41826605 |
107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.40245690 |
108 | Malaria_Homo sapiens_hsa05144 | 0.39111487 |
109 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.38109897 |
110 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.37979366 |
111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36866887 |
112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36499302 |
113 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.36021515 |
114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.34588362 |
115 | Platelet activation_Homo sapiens_hsa04611 | 0.34429870 |
116 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.31958258 |
117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31468133 |
118 | Pathways in cancer_Homo sapiens_hsa05200 | 0.31357000 |
119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28628857 |
120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28401620 |
121 | Salmonella infection_Homo sapiens_hsa05132 | 0.26995793 |
122 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.25987402 |
123 | Hepatitis C_Homo sapiens_hsa05160 | 0.25499166 |
124 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.24962340 |
125 | Alcoholism_Homo sapiens_hsa05034 | 0.24954463 |
126 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.24550776 |
127 | Tuberculosis_Homo sapiens_hsa05152 | 0.22339207 |